Showing 41 - 60 results of 34,872 for search '(((( 5 ng decrease ) OR ( a non decrease ))) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 0.97s Refine Results
  1. 41
  2. 42
  3. 43
  4. 44
  5. 45
  6. 46
  7. 47
  8. 48
  9. 49
  10. 50
  11. 51
  12. 52
  13. 53

    Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

    Published 2025
    “…Background<p>Pralsetinib is a selective RET inhibitor. The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”
  14. 54
  15. 55
  16. 56
  17. 57
  18. 58
  19. 59

    Lower insular perfusion in the DAT group compared with the non-DAT group. by Masashi Takeuchi (1930312)

    Published 2022
    “…In the region of interest-based analysis, decrease extent ratios were higher in the DAT group (N = 12) than in the non-DAT group (N = 38) (D). …”
  20. 60